OTC : ORINF

Orion Oyj

$82.75 USD

$0 (0.0%)

Volume
100
Average Volume
87
Market Capitalization
$11.66B
P/E Ratio
19.45
Dividend Yield
2.12%
Price Target
Year High
$82.75
Year Low
$78.95
Day High
—
Day Low
—
Payout Ratio
$0.41
Current Ratio
$2.64
Company Overview

OTC

Aino Anna Liisa Hurme

Drug Manufacturers - General

Healthcare

ORINF

3882

FI

USD

https://www.orionpharma.com

358 10 4261

N/A

N/A

Liquidity Metrics

0.10

2.64

1.48

0.29

0.41

Sales & Valuation

$1.89B

5.55

9.00

29.37

2.76

Profitability

$3.56

$500.3M

28.54%

35.80%

50.02%

31.34%

P/E Metrics

19.45

0.35

0.35

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

13.80

7/9

$743.78M

$1.87B

$603.79M

$742.09M

Key Metrics (TTM)

$11.42B

5.55

14.51

2.64

50.02%

40.71%

5.14%

3.40%

$29.06

313 days

Company Executives
Name Title
Hao Pan Executive VP of the Branded Products & Member of the Exe. Mgmt. Board
Juhani Kankaanpaa Executive VP of Global Operations & Member of Executive Management Board
Liisa Hurme President, Chief Executive Officer & Chairman of Executive Management Board
Mikko Kemppainen General Counsel, Secretary to the Board & Member of Executive Management Board
Niclas Lindstedt EMBA Executive VP of Animal Health & Member of the Exe. Mgmt. Board
Julia Irene Macharey Executive VP of People & Culture & Member of Management Board
Rene Lindell Chief Financial Officer & Member of Group Executive Management Board
Outi Vaarala Executive VP of Research & Development and Member of the Exe. Mgmt. Board
Berkeley Vincent Executive Vice President of Innovative Medicines & Member of Management Board
Satu Ahomäki Executive VP of Generics and Consumer Health & Member of the Exe. Mgmt. Board
Poll Results

No votes yet today — be the first to share your view!

About Orion Oyj (OTC:ORINF) Stock

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland. ...

Orion Oyj (ORINF) Q2 2026 Earnings Call Transcript

2026-07-17 09:46:18

Orion Oyj (ORINF) Q2 2026 Earnings Call Transcript

Frequently Asked Questions

What is the current Orion Oyj (ORINF) stock price?

Orion Oyj(OTC:ORINF) stock price is $82.75 in the last trading session. During the trading session, ORINF stock reached the peak price of $82.75 while $78.95 was the lowest point it dropped to. The percentage change in ORINF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ORINF stock was $0.

ORINF's industry and sector of operation?

The OTC listed ORINF is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector.

Who are the executives of ORINF?

Hao Pan | Executive VP of the Branded Products & Member of the Exe. Mgmt. Board
Juhani Kankaanpaa | Executive VP of Global Operations & Member of Executive Management Board
Liisa Hurme | President, Chief Executive Officer & Chairman of Executive Management Board
Mikko Kemppainen | General Counsel, Secretary to the Board & Member of Executive Management Board
Niclas Lindstedt EMBA | Executive VP of Animal Health & Member of the Exe. Mgmt. Board

How many employees does ORINF have?

Number of ORINF employees currently stands at 3882. ORINF operates from Orionintie 1, Espoo, UU 02200, FI.

Link for ORINF official website?

Official Website of ORINF is: https://www.orionpharma.com

How do I contact ORINF?

ORINF could be contacted at phone #358 10 4261 and can also be accessed through its website. ORINF operates from Orionintie 1, Espoo, UU 02200, FI.

How many shares of ORINF are traded daily?

The average number of ORINF shares traded daily for last 3 months was 87.

What is the market cap of ORINF currently?

The market value of ORINF currently stands at $11.66B with its latest stock price at $82.75